John Dallow is an author at AstraZeneca (United States) specializing in drug resistance, clinical microbiology, and infection control.
Top concepts
HealthMedicineMicrobiologyDrug ResistanceInfection ControlClinical MicrobiologyAntimicrobial ResistanceAntibioticsAntimicrobial AgentsBacterial Resistance
Publications per year
2007–2014
2
2
Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory
Neil Woodford, John Dallow, Robert L. Hill et al. · International Journal of Antimicrobial Agents · 2007 · 142 citations
Antimicrobial Resistance Gene, Antimicrobial Susceptibility, Health Sciences +10
John Dallow, Linda G. Otterson, Michael D. Huband et al. · International Journal of Antimicrobial Agents · 2014 · 23 citations
Microbiological Interaction Studies, Pulmonary Surfactant, Health Sciences +13
Rows per page
1–2 of 2